AMPH vs. NVO
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or NVO.
Correlation
The correlation between AMPH and NVO is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMPH vs. NVO - Performance Comparison
Key characteristics
AMPH:
-1.05
NVO:
-0.70
AMPH:
-1.49
NVO:
-0.82
AMPH:
0.80
NVO:
0.89
AMPH:
-0.77
NVO:
-0.57
AMPH:
-1.65
NVO:
-1.24
AMPH:
24.51%
NVO:
21.47%
AMPH:
38.51%
NVO:
38.04%
AMPH:
-52.69%
NVO:
-71.32%
AMPH:
-51.88%
NVO:
-39.82%
Fundamentals
AMPH:
$1.50B
NVO:
$369.14B
AMPH:
$3.01
NVO:
$3.16
AMPH:
10.39
NVO:
27.87
AMPH:
2.77
NVO:
1.28
AMPH:
$543.05M
NVO:
$290.40B
AMPH:
$281.28M
NVO:
$245.88B
AMPH:
$200.15M
NVO:
$148.56B
Returns By Period
In the year-to-date period, AMPH achieves a -15.76% return, which is significantly lower than NVO's 2.39% return. Over the past 10 years, AMPH has underperformed NVO with an annualized return of 8.68%, while NVO has yielded a comparatively higher 16.41% annualized return.
AMPH
-15.76%
-14.04%
-34.77%
-41.43%
12.26%
8.68%
NVO
2.39%
8.61%
-35.69%
-27.87%
25.59%
16.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. NVO — Risk-Adjusted Performance Rank
AMPH
NVO
AMPH vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMPH vs. NVO - Dividend Comparison
AMPH has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.64%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.64% | 1.68% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% |
Drawdowns
AMPH vs. NVO - Drawdown Comparison
The maximum AMPH drawdown since its inception was -52.69%, smaller than the maximum NVO drawdown of -71.32%. Use the drawdown chart below to compare losses from any high point for AMPH and NVO. For additional features, visit the drawdowns tool.
Volatility
AMPH vs. NVO - Volatility Comparison
The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 7.04%, while Novo Nordisk A/S (NVO) has a volatility of 13.94%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMPH vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities